Hims Reviews
Honest patient reviews and ratings for Hims peptide therapy services.
Telehealth Ally is editorially independent. Revenue never influences our rankings.
Our Verdict
Hims earns a 4.0/5 rating from 10 patient reviews, with pricing starting at $199/month. They offer async telehealth consultations.
Quick Facts
Consultation
Async Telehealth
Lab Testing
Not included
Peptides Offered
2
Shipping
3-5 business days
Hims Weight Loss Review 2026: Pricing, How It Works, and Who It's Best For
Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026.
Hims & Hers (NYSE: HIMS) is one of the largest telehealth companies in the US, serving millions of customers across sexual health, dermatology, mental health, and weight loss. Following a March 9, 2026 settlement with Novo Nordisk, Hims exited compounding and now operates as an authorized distributor of brand-name GLP-1 medications — injectable Wegovy, oral Wegovy, and Ozempic — with cash-pay pricing starting at $149/month.
As a publicly traded company, Hims carries audited financials and SEC oversight that smaller telehealth startups don't. Whether that translates to a better weight loss experience depends on what you need from a provider.
How does Hims' weight loss program work?
Hims uses an async-only model — no video or phone consultations. Most patients get a prescription decision within 24 hours, and medication ships free in 3–5 business days.
- Online intake — Complete a medical questionnaire covering health history, current medications, BMI, and weight goals. The intake screens for contraindications (e.g., personal or family history of medullary thyroid carcinoma, MEN 2 syndrome).
- Provider evaluation — A board-certified physician or licensed provider reviews your submission asynchronously. Most patients hear back within 24 hours.
- Medication shipped — If approved, medication ships free, arriving in 3–5 business days.
- Ongoing support — Unlimited provider messaging for dose adjustments, side effect questions, and follow-up.
How much does Hims weight loss cost per month?
Following the March 9, 2026 Novo Nordisk settlement, Hims exited compounding. Branded GLP-1 medications are now available at Novo Nordisk's adjusted self-pay prices: oral Wegovy starts at $149/month, injectable Wegovy at $299/month, Zepbound (tirzepatide) at $399/month.
Pricing last verified April 2026. We update pricing data monthly. Contact us if you spot an error.
| Medication | Monthly Cost | Notes |
|---|---|---|
| Oral Wegovy (semaglutide pill) | $149/mo | Cash-pay; FDA-approved oral GLP-1 |
| Injectable Wegovy (semaglutide) | $299/mo | Cash-pay; FDA-approved weekly injection |
| Ozempic (semaglutide) | $149/mo | Cash-pay; FDA-approved for type 2 diabetes, prescribed off-label for weight loss |
| Brand Zepbound (tirzepatide) | $399/mo | Cash-pay; FDA-approved for chronic weight management |
Pricing aligns with other telehealth platforms operating under Novo Nordisk's adjusted self-pay structure. Compounded semaglutide is no longer available from Hims.
What medications does Hims offer for weight loss?
As of March 9, 2026, Hims exclusively offers FDA-approved branded medications following its settlement with Novo Nordisk:
- Oral Wegovy (semaglutide pill) — FDA-approved oral GLP-1 receptor agonist for weight management ($149/mo cash-pay). Hims is an authorized Novo Nordisk distributor.
- Injectable Wegovy (semaglutide) — FDA-approved weekly subcutaneous injection for weight management ($299/mo cash-pay).
- Ozempic (semaglutide) — FDA-approved for type 2 diabetes; often prescribed off-label for weight loss ($149/mo cash-pay).
- Brand Zepbound (tirzepatide) — Dual GIP/GLP-1 agonist; FDA-approved for chronic weight management ($399/mo cash-pay).
Compounded semaglutide, including the previously offered oral compounded tablets, is no longer available from Hims.
Clinical Protocol
Hims operates as a brand-only, async-only platform — no compounded medications, no video consultations, no tirzepatide as of early 2026.
What doses does Hims start patients on?
Titration schedules vary by formulation:
- Oral Wegovy 4 mg tier: 3 mg/day × 4 weeks → 7 mg/day × 4 weeks → 14 mg/day maintenance
- Oral Wegovy 9–25 mg tier: 3 mg/day × 4 weeks → 7 mg/day × 4 weeks → 14 mg/day × 4 weeks → 25 mg/day maintenance
- Wegovy injectable (semaglutide): 0.25 mg/week × 4 weeks → 0.5 mg/week × 4 weeks → 1.0 mg/week × 4 weeks → 1.7 mg/week × 4 weeks → 2.4 mg/week maintenance
- Wegovy HD (7.2 mg): Higher-dose option for patients who plateau at 2.4 mg. Available only after completing full standard titration. Insurance-dependent.
What medications does Hims currently prescribe?
- Brand oral Wegovy (4 mg, ~$149/mo; 9–25 mg, ~$299/mo cash-pay) — FDA-approved
- Brand Wegovy injectable — FDA-approved; cash-pay or insurance
- Brand Ozempic (semaglutide; primarily indicated for type 2 diabetes, prescribed off-label for weight management) — FDA-approved
- Wegovy HD (semaglutide 7.2 mg) — FDA-approved April 2026; insurance-dependent
- No tirzepatide — Hims dropped Zepbound from their formulary in early 2026. Patients who need tirzepatide access should evaluate Ro, Calibrate, or Found.
- No compounded medications — Hims exited compounding following a March 9, 2026 settlement with Novo Nordisk
Does Hims require lab work before prescribing?
No. Hims does not include or require any lab testing. Patients escalating to Wegovy HD or on long-term semaglutide should discuss periodic monitoring of thyroid function, GI markers, and metabolic panels with their primary care provider. Hims does not provide this monitoring.
Who prescribes at Hims, and how does the consultation work?
Hims' prescribers are board-certified physicians (MD/DO) or licensed providers (NP/PA). Hims does not specify prescriber seniority for individual patient cases. The consultation model is async-only: providers review intake forms and respond via secure messaging, typically within 24 hours. No video consultations are offered.
How often does Hims check in with patients?
No scheduled follow-up cadence. Hims offers unlimited provider messaging for dose questions and adjustments, but all contact is patient-initiated. Dose escalation decisions are made through the message thread, not structured visits.
How does Hims manage side effects?
Provider messaging is available for side effect questions. No structured antiemetic protocol is documented. Standard guidance: remain at your current dose until tolerating well before escalating. No dietary coaching, behavioral support, or nutritional guidance is included.
How effective is Hims weight loss treatment?
The clinical evidence for semaglutide and tirzepatide is well-established:
- Semaglutide (STEP 1): 14.9% mean body weight loss over 68 weeks with 2.4mg weekly semaglutide vs 2.4% with placebo (Wilding et al., NEJM 2021).
- Tirzepatide (SURMOUNT-1): 22.5% mean body weight loss at the highest dose (15mg) over 72 weeks vs 2.4% with placebo (Jastreboff et al., NEJM 2022).
Individual results vary. These trials were conducted with brand-name medications — the same products Hims now exclusively dispenses.
What are the pros of Hims weight loss?
- Publicly traded company — Financial statements are audited and public; subject to SEC oversight. This provides accountability that private startups lack.
- Massive scale — Hims serves millions of patients, suggesting operational maturity and supply chain reliability.
- FDA-approved medications only — All offerings are brand-name, FDA-approved products. No compounded medication risk.
- Oral Wegovy option — The FDA-approved semaglutide pill at $149/mo is a practical alternative for patients who prefer oral dosing over injections.
- Authorized Novo Nordisk distributor — Direct partnership ensures supply chain reliability and authentic branded product.
- Competitive cash-pay pricing — Oral Wegovy and Ozempic at $149/mo are in line with Novo Nordisk's adjusted self-pay structure across all platforms.
What are the cons of Hims weight loss?
- Injectable Wegovy at $299/mo is expensive — Patients who previously paid $199/mo for compounded semaglutide will now pay more for the injectable brand option. The oral Wegovy at $149/mo partially offsets this, but injectable users face a price increase.
- No video consultations — Async-only care model.
- No lab testing — Metabolic blood work is not included or required.
- Limited to GLP-1 medications — No broader peptide or weight management drug options.
- Compounded option gone — Patients who relied on Hims' $199/mo compounded semaglutide must either switch to brand (at $149–$299/mo) or find another provider.
Who is Hims best for?
- Patients who want FDA-approved branded GLP-1 medications with reliable supply from an authorized distributor
- People who prefer oral semaglutide — Hims is one of the few telehealth platforms offering FDA-approved oral Wegovy at $149/mo
- Existing Hims customers who already use the platform for other health services
- Patients comfortable with async digital care who want public company accountability
Who should look elsewhere?
- Patients seeking the lowest possible price for injectables — Injectable Wegovy at $299/mo is the higher end of the branded market. Check if your insurer covers Wegovy before paying cash-pay.
- Patients wanting comprehensive coaching — Found and Calibrate offer more holistic programs
- Those needing video consultations or lab testing — Calibrate is a better fit
- Patients who previously used Hims for compounded semaglutide — The $199/mo option is gone; evaluate the oral Wegovy ($149/mo) or injectable ($299/mo) against other platforms
Is Hims weight loss worth it?
For branded GLP-1 weight loss, Hims is a legitimate option: publicly traded, audited financials, authorized Novo Nordisk distributor, FDA-approved medications only. The oral Wegovy at $149/mo stands out — few telehealth platforms offer it. Injectable Wegovy at $299/mo is worth comparing against other platforms or checking insurer coverage before paying cash. Hims works best for patients already in its ecosystem, those who prefer oral semaglutide, or those who want public company accountability.
Rating: 3.8/5
Frequently Asked Questions
Is Hims weight loss legit? Yes. Hims & Hers (NYSE: HIMS) is a publicly traded telehealth company with audited financials and SEC oversight. Their GLP-1 weight loss program uses licensed physicians and exclusively provides FDA-approved branded medications through an authorized Novo Nordisk distribution agreement. The async-only model is a real limitation, but the platform is legitimate.
How much does Hims weight loss cost without insurance? As of April 2026, Hims offers oral Wegovy (semaglutide pill) starting at $149/month and injectable Wegovy at $299/month cash-pay. Ozempic is also available at $149/month. Zepbound is $399/month cash-pay. Compounded semaglutide is no longer available.
Does Hims take insurance for weight loss? Hims assists with prior authorization for brand Wegovy through insurance. The cash-pay medication prices ($149–$299/month) are available without insurance. Hims no longer offers compounded semaglutide as of March 9, 2026.
How do I cancel Hims weight loss? You can cancel your Hims weight loss subscription through your account settings online or by contacting Hims support. The subscription is month-to-month with no long-term commitment required.
Is Hims' semaglutide FDA-approved? Yes. As of April 2026, Hims exclusively offers FDA-approved branded semaglutide: oral Wegovy (pill), injectable Wegovy, and Ozempic. All are manufactured by Novo Nordisk. Hims became an authorized distributor following the March 9, 2026 settlement that ended compounding.
How does Hims compare to Ro for weight loss? Both platforms now offer branded-only GLP-1 medications under Novo Nordisk's self-pay pricing. Hims' oral Wegovy starts at $149/mo — comparable pricing to Ro's brand offerings under the same structure. Hims stands out for its oral Wegovy access and public company accountability. Neither platform offers compounded semaglutide as of April 2026.
Data Sources & Methodology
Pricing and protocol data sourced from Hims & Hers's public website and newsroom, and corroborated via third-party reporting on the March 9, 2026 Novo Nordisk settlement. Verified March 31, 2026. Patient experience data drawn from public reviews (Google, Trustpilot, Reddit) and independent patient outreach. Telehealth Ally has no commercial relationship with this provider. Rankings and ratings are editorial-only.
Related Resources
- Hims Provider Profile — Medications, pricing, and consultation details
- Hims vs Ro: Head-to-Head Comparison — Which budget platform wins?
- Henry Meds vs Hims — Comparing two popular GLP-1 providers
- Best GLP-1 Weight Loss Programs 2026 — All major providers ranked
- GLP-1 Cost & Insurance FAQ — What you'll actually pay
- Hers vs Hims Weight Loss — Are they actually different?
- Mochi Health vs Hims — Specialist vs mass-market approach
Sarah Chen
Lead Health Editor
Sarah covers telehealth and digital health access. She has spent 8 years in health journalism, previously writing for health policy publications. She leads editorial at Telehealth Ally.
All Patient Reviews (10)
Lost 26 pounds in five months — compounded sema worked
Started on 0.25mg in October, titrated to 1mg by January. Down 26 lbs and my clothes fit differently for the first time in years. The questionnaire onboarding took maybe 15 minutes and I had a prescription approval the next morning. I appreciated that Hims offered both compounded and brand-name options upfront — my provider actually explained the difference instead of just defaulting to one. Price for compounded was competitive. No video consult, but the async messaging has been more than adequate for my questions.
March 12, 2026
Compounded to brand-name upgrade was easier than expected
Started on compounded semaglutide for three months, then my provider suggested trying brand-name Ozempic when supply stabilized. Hims handled the prescription transition without me having to restart the clinical intake. I paid more for brand-name but wanted the consistency. Down 17 lbs since November. The support team responded to my insurance question within a few hours, though they couldn't actually handle the prior auth process — that was on me. No video consult option is the right trade-off for the price; I don't need it.
February 25, 2026
Six months in, down 31 lbs — best decision I made last year
Started at 0.25mg in August, now at 1.7mg, lost 31 lbs total. Side effects were mild — nausea for about two weeks at the 0.5mg step-up, nothing after that. Hims sent a clear titration schedule with the first shipment which made dosing simple. The care team responded to my two check-ins within hours each time. Women's health extension also caught that I had an unrelated question about my cycle — the provider addressed it without me having to open a separate issue. Genuinely impressed.
February 20, 2026
Great for people who don't want to schedule calls — async works
I specifically wanted async because my schedule is unpredictable. Hims delivered that. The intake was a questionnaire, got approved, medication arrived. Five months in, down 22 lbs. The app makes it easy to message the care team and track refills. I knocked one star because my state has weird restrictions and I had to contact support twice to clarify availability before I could confirm I could even enroll — that info should be surfaced before you fill out the whole questionnaire.
February 3, 2026
Switched from brand-name Wegovy to compounded — half the price
I was on brand-name Wegovy through my insurance for 8 months but coverage ended and the cash price was absurd. Hims let me switch to compounded semaglutide without starting over from scratch — I explained my history and they set me up at 1mg to match my existing dose. The transition was smooth. Same appetite suppression, same results trajectory. I've continued losing about 1.5 lbs per week. The app is clean and messaging the care team takes under a minute. Happy I made the switch.
January 28, 2026
Second shipment delayed 10 days — broke my dosing schedule
Onboarding and first shipment were smooth — questionnaire approved same day, medication in 7 days. The second month, I got a tracking number but the package didn't move for four days. I messaged support and they said to allow up to 14 business days. I ended up skipping a dose because I was out of medication for 3 days. The hunger came back noticeably and it took another week to stabilize. Support apologized but gave no explanation and offered no expedited shipping going forward. Down 8 lbs total, which is fine, but the reliability issue is a real concern.
January 18, 2026
Solid medication, wish they offered lab panels
Four months in, down 20 lbs. The compounded semaglutide at this price point is hard to argue with. The onboarding questionnaire is thorough and I was approved the same day. My one persistent gripe is that Hims does zero lab testing. I wanted a baseline lipid panel and metabolic panel before starting and had to book those through my GP separately. For a $200+ monthly spend I expected at least optional labs. But the medication management itself, the dosing guidance, and the care team response times have all been solid.
January 5, 2026
Onboarding was the fastest I've seen — prescription same day
Filled out the intake form on a Tuesday morning. Had a prescription approval in my inbox by that afternoon. Medication shipped the next day and arrived in 6 days. The whole thing felt frictionless compared to what I expected from a telehealth service. I'm three months in on compounded semaglutide and down 18 lbs. The async model suits me — I work weird hours and can't schedule video calls easily. When I messaged the care team about a dosing question at 9pm I had an answer by 7am.
December 15, 2025
Medication works but no video option left me uncertain about side effects
I've lost 12 lbs in 10 weeks which is real progress. The medication is effective. But around week six I had some persistent fatigue and mild heart palpitations that worried me. I sent a message through the app and got a response the next day saying this was likely unrelated to semaglutide and to monitor it. That's an appropriate answer, but I really wanted to talk to someone face-to-face. The no-video-consult model saved me money but felt limiting at that moment. I ended up going to my GP who ruled out anything serious. Still on Hims, still losing weight, but wish there was a video option even at extra cost.
November 30, 2025
Denied in my state after completing full intake — time wasted
Spent 20 minutes filling out the detailed health questionnaire, uploaded my ID, entered payment — and then got a message that Hims doesn't currently offer GLP-1 medications in my state. There is no mention of state restrictions anywhere visible on the sign-up flow. I only found out at the end. Customer service refunded my first charge quickly, I'll give them that. But the entire process felt designed to get you through the funnel first and disclose limitations after. If you're not in one of the major metro states, check availability before you invest time in the intake.
October 14, 2025
Frequently Asked Questions
Is Hims legit?
Hims has 10 patient reviews with an average rating of 4.0/5. They offer async telehealth consultations. Founded in 2017, they are based in San Francisco, CA.
How much does Hims cost?
Hims pricing starts at $199/month. They offer 2 peptides including Semaglutide, Tirzepatide.
What peptides does Hims offer?
Hims offers 2 peptides: Semaglutide, Tirzepatide.
Have you used Hims?
Share your honest experience to help others make informed decisions. Verified reviews are prioritized — we'll ask you to confirm via email.
Get weekly GLP-1 pricing updates
We track prices so you don't have to.
No spam. Unsubscribe anytime.
Related Guides
Best Telehealth Providers for Tirzepatide 2026: Ranked by Price and Care
The best telehealth providers for tirzepatide in 2026, ranked by price, protocol, and care quality. From $278/month compounded to brand Zepbound via insurance. No provider paid for placement.
Read guide →Is Compounded Semaglutide Legal and Safe in 2026?
Is compounded semaglutide still legal? We break down the current FDA rules, 30 new warning letters, SAFE Drugs Act, Hims exiting compounded, and what this means for your prescription.
Read guide →Compounded Tirzepatide 2026: What's Happening and What Patients Should Do
Compounded tirzepatide is under active FDA enforcement as of April 2026 — supply is declining but not yet at zero. The 503B enforcement discretion ended over a year ago (March 2025); the FDA has now issued 50+ warning letters including a 30-letter batch in April 2026. Here's what patients need to know and what to do.
Read guide →